P53 protein in proliferation, repair and apoptosis of cells

Protoplasma

Volumn 251, Issue 3, 2014, Pages 525-533

  Wawryk Gawda, Ewelina ^a   Chylińska Wrzos, Patrycja ^a   Lis Sochocka, Marta ^a   Chłapek, Katarzyna ^b   Bulak, Kamila ^a   Jędrych, Marian ^a   Jodłowska Jędrych, Barbara ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b CRACOW UNIVERSITY OF ECONOMICS   (Poland)

Author keywords

Apoptosis; Cladribine; p53 protein; Proliferation

Indexed keywords

RATTUS;

CLADRIBINE; PROTEIN P53;

ANIMAL; APOPTOSIS; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; EMBRYOLOGY; EPITHELIUM CELL; FEMALE; PHYSIOLOGY; RANDOMIZATION; RAT; UPREGULATION; UTERUS; WISTAR RAT;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CLADRIBINE; EPITHELIAL CELLS; FEMALE; RANDOM ALLOCATION; RATS; RATS, WISTAR; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION; UTERUS;

EID: 84926638384     PISSN: 0033183X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00709-013-0548-1     Document Type: Article

References (23)

1. Borner MM, Joncourt F, Hotz MA (1997) Type of inducing signal regulates transactivation by p53. Biochim Biophys Acta 1358(3): 314-320
2. Chmielewski M, Linke K, ZabelM (2008) Metody wykrywania zjawiska apoptozy w komórkach wątrobowych in situ. [Methods of detecting the phenomenon of apoptosis in liver cells in situ.] (in Polish). Nowiny Lekarskie 77(3):223-226
3. De Viron E, Knoops L, Connerotte T, Smal C, Michaux L, Saussoy P, Vannuffel P, Beert E, Vekemans MC, Hermans C, Bontemps F, Van Den Neste E (2009) Impaired up-regulation of polo-like kinase 2 in B-cell chronic lymphocytic leukaemia lymphocytes resistant to fludarabine and 2-chlorodeoxyadenosine: a potential marker of defective damage response. Br J Haematol 147(5):641-652. doi:10. 1111/j.1365-2141.2009.07900.x
4. Di Giovanni S, Rathore K (2012) P53-Dependent pathways in neurite outgrowth and axonal regeneration. Cell Tissue Res 349(1):87-95. doi:10.1007/s00441-011-1292-5
5. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133(4):1710-1715
6. Jędrych M, Wawryk-Gawda E, Jodłowska-Jędrych B, Chylińska-Wrzos P, Jasiński L (2013) Immunohistochemical evaluation of cell proliferation and apoptosis marker in ovarian surface epithelial cells of cladribine-treated rats. Protoplasma. doi:10.1007/s00709-012-0461-z
7. Johnston JB (2011) Mechanism of action of pentostatin and cladribine in hairy cell leukemia. Leuk Lymphoma 52(Suppl 2):43-45. doi:10. 3109/10428194.2011.570394
8. Karagece Yalçin U, Seçkın S (2012) The expression of p53 and COX-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases. Turk Patoloji Derg 28(2):119-127. doi:10.5146/tjpath.2012. 01110
9. Klöpfer A, Hasenjäger A, Belka C, Schulze-Osthoff K, Dörken B, Daniel PT (2004) Adenine deoxynucleotides fludarabine and cladribine induce apoptosis in a CD95/Fas receptor, FADD and caspase-8- independent manner by activation of the mitochondrial cell death pathway. Oncogene 23(58):9408-9418. doi:10.1038/sj.onc. 1207975
10. Korzeniewska-Dyl I (2007) Kaspazy-struktura i funkcja. [Caspases- structure and function.]. Pol Merkur Lekarski 23(138):403-407
11. Laptenko O, Prives C (2006) Transcriptional regulation by p53: one protein, many possibilities. Cell Death Differ 13(6):951-961
12. Liu Y, Kulecz-Martin M (2001) P53 protein at the hub of cellular DNA damage response pathway through sequence-specific and nonsequence- specific DNA binding. Carcinogenesis 22(6):851-860
13. Marcondes FK, Bianchi FJ, Tanno AP (2002) Determination of the estrous cycle phases of rats: some helpful considerations. Braz J Biol 62(4A):609-614
14. Mendoza-Rodríguez CA,Merchant-Larios H, Segura-ValdezMd Mde L, Moreno-Mendoza N, CruzME, Arteaga-López P, Camacho-Arroyo I, Dominguez R, CerbónM (2002) Expression of p53 in luminal and glandular epithelium during the growth and regression of rat uterus during the estrous cycle. Mol Reprod Dev 61(4):445-452
15. Muskhelishvili L, Latendresse JR, Kodell RL, Henderson EB (2003) Evaluation of cell proliferation in rat tissues with BrdU, PCNA, Ki-67(MIB-5) immunohistochemistry and in situ hybridization for histone mRNA. J Histochem Cytochem 51(12):1681-1688
16. Nocentini G (1996) Ribonucleotide reductase inhibitors: new strategies for cancer chemotherapy. Crit Rev Oncol Hematol 22(2):89-126
17. Pekova S, Mazal O, Cmejla R, Hardekopf DW, Plachy R, Zejskova L, Haugvicova R, Jancuskova T, Karas M, Koza V, Smolej L, Bezdickova L, Kozak T (2011) A comprehensive study of TP53 mutations in chronic lymphocytic leukemia: analysis of 1287 diagnostic and 1148 follow-up CLL samples. Leuk Res 35(7):889-898. doi:10.1016/j.leukres.2010.12.016
18. Sato T, Fukazawa Y, Kojima H, Enari M, Iguchi T, Ohta Y (1997) Apoptotic cell death during the estrous cycle in the rat uterus and vagina. Anat Rec 248(1):76-83
19. Sznarkowska A, Olszewski R, Zawacka-Pankau J (2010) Farmakologiczna aktywacja supresora nowotworu, natywnego białka p53 jako obiecująca strategia zwalczania nowotworów. [Pharmacological activation of tumor suppressor, wild-type p53 as a promising strategy to fight cancer.] (in Polish). Postepy Hig Med Dośw (online) 64:396- 407
20. Takimoto R, El-Deiry WS (2000) Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNAbinding site. Oncogene 19(14):1735-1743
21. Wawryk-Gawda E, Chylińska-Wrzos P, Jodłowska-Jędrych B, Lis-Sochocka M (2011) Use of selected purine analogs in neoplastic and autoimmune diseases. Ann UMCS Sect DDD 24(4):29-47
22. Westwood FR (2008) The female rat reproductive cycle: a practical histological guide to staging. Toxicol Pathol 36:375-384. doi:10. 1177/0192623308315665
23. Yi L, Lu C, Hu W, Sun Y, Levine AJ (2012) Multiple roles of p53-related pathways in somatic cell reprogramming and stem cell differentiation. Cancer Res 72(21):5635-5645. doi:10.1158/0008-5472.CAN-12-1451